Recurrent ischaemic events prior to CEA in patients receiving medical therapy
| Study | Patients with recurrent ischaemic events, n (% of total patients undergoing CEA) | Medical therapy prior to CEA |
| Yoshida et al17 | 7 (100) | Dual antiplatelet therapy in all patients with recurrent events*. |
| Ballotta et al18 | 21 (36.8) | All with recurrent events were taking at least one antiplatelet; 13 were on a statin. |
| Yoshida et al19 | 17 (100) | Dual antiplatelet therapy in all patients with recurrent events. |
| Takai et al20 | NR | – |
| Kashiwazaki et al21 | 4 (25.0) | At least one antiplatelet. |
| Nardi et al22 | 23 (71.9) | At least one antiplatelet. |
*Antiplatelet medications consist of aspirin, P2Y12 inhibitor (ie, clopidogrel) and cilostazol.
CEA, carotid endarterectomy; NR, not reported.